A Phase 1b Trial of AR-42 With Pomalidomide in Relapsed Multiple Myeloma

Trial Profile

A Phase 1b Trial of AR-42 With Pomalidomide in Relapsed Multiple Myeloma

Suspended
Phase of Trial: Phase I

Latest Information Update: 10 Jul 2017

At a glance

  • Drugs AR 42 (Primary) ; Pomalidomide (Primary) ; Dexamethasone
  • Indications Multiple myeloma
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Jul 2017 Status changed from recruiting to suspended.
    • 09 May 2016 Status changed from not yet recruiting to recruiting.
    • 07 Apr 2016 Planned initiation date changed from 1 Dec 2015 to 1 Jun 2016, according to ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top